These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10451813)

  • 1. Decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone.
    Haenggi W; Bersinger NA; Mueller MD; Birkhaeuser MH
    Gynecol Endocrinol; 1999 Jun; 13(3):202-5. PubMed ID: 10451813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
    Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
    J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women.
    Genazzani AD; Gamba O; Nappi L; Volpe A; Petraglia F
    Maturitas; 1997 Sep; 28(1):27-33. PubMed ID: 9391992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effect of tibolone and transdermal estradiol on triglyceride level in hypertriglyceridemic and normotriglyceridemic postmenopausal women.
    Dansuk R; Unal O; Karageyim Y; Esim E; Turan C
    Gynecol Endocrinol; 2004 May; 18(5):233-9. PubMed ID: 15346658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users.
    Hänggi W; Bersinger N; Altermatt HJ; Birkhäuser MH
    Maturitas; 1997 Jun; 27(2):133-43. PubMed ID: 9255748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
    Godsland IF
    Fertil Steril; 2001 May; 75(5):898-915. PubMed ID: 11334901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women.
    Prelevic GM; Bartram C; Wood J; Okolo S; Ginsburg J
    Gynecol Endocrinol; 1996 Dec; 10(6):413-20. PubMed ID: 9032569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women.
    Castelo-Branco C; Vicente JJ; Figueras F; Sanjuan A; Martínez de Osaba MJ; Casals E; Pons F; Balasch J; Vanrell JA
    Maturitas; 2000 Feb; 34(2):161-8. PubMed ID: 10714911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of an estradiol-releasing vaginal ring versus tibolone in postmenopausal women: a transvaginal color Doppler study.
    Botsis D; Kassanos D; Kalogirou D; Antoniou G; Karakitsos P; Zourlas PA
    Maturitas; 1997 May; 27(1):77-83. PubMed ID: 9158081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of post-oophorectomy bone loss with Tibolone.
    Lyritis GP; Karpathios S; Basdekis K; Grigoriou O; Katostaras T; Paspati I; Stamatopoulos T; Siampalioti G; Lyritis PG
    Maturitas; 1995 Nov; 22(3):247-53. PubMed ID: 8746883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.
    Ylikorkala O; Cacciatore B; Paakkari I; Tikkanen MJ; Viinikka L; Toivonen J
    Fertil Steril; 1998 May; 69(5):883-8. PubMed ID: 9591497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
    Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
    Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women.
    Hänggi W; Lippuner K; Jaeger P; Birkhäuser MH; Horber FF
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):691-9. PubMed ID: 9713556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormonal replacement decreases plasma levels of endothelin-1.
    Ylikorkala O; Orpana A; Puolakka J; Pyörälä T; Viinikka L
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3384-7. PubMed ID: 7593457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The short-term effects of different regimens of hormone replacement therapy on left ventricular structure and performance in healthy postmenopausal women. A prospective, controlled echocardiographic study.
    Fenkci V; Yilmazer M; Alpaslan M; Onrat E; Fenkci S
    Gynecol Obstet Invest; 2003; 55(3):139-44. PubMed ID: 12865592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid effects, effectiveness and acceptability of tibolone versus transdermic 17 beta-estradiol for hormonal replacement therapy in women with surgical menopause.
    Mendoza N; Suárez AM; Alamo F; Bartual E; Vergara F; Herruzo A
    Maturitas; 2000 Nov; 37(1):37-43. PubMed ID: 11099872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
    Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.